Results 21 to 30 of about 45,210 (266)
Early hypersalivation as a risk marker for inflammatory adverse reactions to clozapine. [PDF]
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 4, December 2026.
Miyahara K, Ishida T, Ino H, Nunomura A.
europepmc +2 more sources
Objective Clozapine may cause serious side effects despite benefits in patients with schizophrenia. Thus, an accurate understanding of the side-effect profile of clozapine is extremely important in the management of its administration to patients with ...
Yuta Kawakita +6 more
doaj +1 more source
Clozapine prescribing during follow-up of a first-episode psychosis cohort
Introduction Of those with schizophrenia, one third develop treatment-resistant illness. Nearly 60% of these benefit from clozapine- the only antipsychotic medication licensed in this group.
R. Rowntree +7 more
doaj +1 more source
Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders - A case series [PDF]
Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorders. Currently, numerous controlled short-term studies are available for clozapine, olanzapine, risperidone or quetiapine, but long-term data are still ...
Hummel, B. +5 more
core +1 more source
Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors. [PDF]
The widely used atypical antipsychotic clozapine is a potent competitive antagonist at 5-HT(3) receptors which may contribute to its unique psychopharmacological profile. Clozapine binds to 5-HT(3) receptors of various species.
Gerhard Rammes +28 more
core +2 more sources
How Non-Medical Prescribing may Impact on the Service Development of a Clozapine Clinic [PDF]
The purpose of this article is to discuss the possible implications of applying non medical prescribing practices to a Clozapine clinic in the Rotherham, Doncaster and South Humber Mental Health NHS Foundation Trust (RDASH). To reflect on such issues the
Woolhouse, Nicola
core +2 more sources
This is a small case study on a patient on clozapine and it's absence on the pharmacy medication record, healthy living advice and a question on smoking ...
Khan, Nahim
core +2 more sources
Supplemental material, sj-jpeg-1-tpp-10.1177_20451253211072341 for Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study by Claas-Frederik Johannsen, Tonny Studsgaard Petersen, Jimmi Nielsen ...
Anders Fink-Jensen (724822) +5 more
core +1 more source
Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
Background: Clozapine formulation has been shown to affect plasma concentrations of clozapine and norclozapine. Changes in formulation might result in toxicity or treatment failure.
Farinaz Keshavarzi +3 more
doaj +1 more source
Factors predicting serum clozapine levels in Middle Eastern patients: an observational study
Background Despite its superiority over other drugs for psychosis, clozapine remains underused and is associated with many clinical challenges, including difficulties in predicting therapeutic serum levels (350-600 ng/mL).
Ahmed Hassab Errasoul +1 more
doaj +1 more source

